Abstract
Induced pluripotent stem cells have displayed great potential in disease investigation and drug development applications. However, selection of reprogramming factors in each cell type or disease state is both expensive and time consuming. To deal with this kind of situation, a fast computational framework was developed by optimize the reprogramming factors via the protein interaction network and gene functional profiles. It can be used to select reprogramming factors from millions of possibilities. It is anticipated that the novel approach will become a very useful tool for both basic research and drug development.
Keywords: Stem cells, Reprogramming factors, Protein interaction network, Gene functional profiles, Disease investigation, pluripotent stem cells, cDNA sequences, Yamanaka factors, Candidate pluripotency genes, STRING network, Dijkstra, ’, s algorithm, HGF-induced hepatomegaly, ESCs, c-Myc, Gene Ontology
Protein & Peptide Letters
Title: Selection of Reprogramming Factors of Induced Pluripotent Stem Cells Based on the Protein Interaction Network and Functional Profiles
Volume: 19 Issue: 1
Author(s): Tao Huang, Yu-Dong Cai, Lei Chen, Le-Le Hu, Xiang-Yin Kong, Yi-Xue Li and Kuo-Chen Chou
Affiliation:
Keywords: Stem cells, Reprogramming factors, Protein interaction network, Gene functional profiles, Disease investigation, pluripotent stem cells, cDNA sequences, Yamanaka factors, Candidate pluripotency genes, STRING network, Dijkstra, ’, s algorithm, HGF-induced hepatomegaly, ESCs, c-Myc, Gene Ontology
Abstract: Induced pluripotent stem cells have displayed great potential in disease investigation and drug development applications. However, selection of reprogramming factors in each cell type or disease state is both expensive and time consuming. To deal with this kind of situation, a fast computational framework was developed by optimize the reprogramming factors via the protein interaction network and gene functional profiles. It can be used to select reprogramming factors from millions of possibilities. It is anticipated that the novel approach will become a very useful tool for both basic research and drug development.
Export Options
About this article
Cite this article as:
Huang Tao, Cai Yu-Dong, Chen Lei, Hu Le-Le, Kong Xiang-Yin, Li Yi-Xue and Chou Kuo-Chen, Selection of Reprogramming Factors of Induced Pluripotent Stem Cells Based on the Protein Interaction Network and Functional Profiles, Protein & Peptide Letters 2012; 19 (1) . https://dx.doi.org/10.2174/092986612798472884
DOI https://dx.doi.org/10.2174/092986612798472884 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Estrogen Receptor Signaling: Impact on Cell Functions
Current Signal Transduction Therapy Paving Roads for New Drugs in Oncology
Recent Patents on Anti-Cancer Drug Discovery Cancer Preventive Phytochemicals as Speed Breakers in Inflammatory Signaling Involved in Aberrant COX-2 Expression
Current Cancer Drug Targets Novel non-invasive Adjunctive Techniques for Early Oral Cancer Diagnosis and Oral Lesions Examination
Current Pharmaceutical Design Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
Current Pharmaceutical Design “Letting the Air In” Can Set the Stage for Tumor Recurrences
Current Cancer Therapy Reviews Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals
Current Pharmaceutical Biotechnology The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Current Pharmaceutical Design The Multiple Aspects of Stroke and Stem Cell Therapy
Current Molecular Medicine The Beneficial Effects of Sulfur-containing Amino Acids on Cisplatininduced Cardiotoxicity and Neurotoxicity in Rodents
Current Medicinal Chemistry Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Current Drug Targets Phytoestrogens and Prostate Cancer
Current Drug Targets DNA Repair Proteins as Molecular Therapeutics for Oxidative and Alkylating Lung Injury
Current Gene Therapy Condition Optimization and Production of Extracellular l-Arginine Deiminase from Vibrio Alginolyticus 1374
Current Biotechnology Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
Current Pharmaceutical Design The Role of Apoptotic Dysfunction in the Pathogenesis of Endometriosis
Current Women`s Health Reviews Matrix Metalloproteinase Dependent Cleavage of Cell Adhesion Molecules in the Pathogenesis of CNS Dysfunction with HIV and Methamphetamine
Current HIV Research Gut Inflammation: Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities
Current Pharmaceutical Design EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?
Current Genomics